Effective delivery of Complex Innovative Design (CID) cancer trials—A consensus statement

The traditional cancer drug development pathway is increasingly being superseded by trials that address multiple clinical questions. These are collectively termed Complex Innovative Design (CID) trials. CID trials not only assess the safety and toxicity of novel anticancer medicines but also their e...

Descripción completa

Detalles Bibliográficos
Autores principales: Blagden, Sarah P., Billingham, Lucinda, Brown, Louise C., Buckland, Sean W., Cooper, Alison M., Ellis, Stephanie, Fisher, Wendy, Hughes, Helen, Keatley, Debbie A., Maignen, Francois M., Morozov, Alex, Navaie, Will, Pearson, Sarah, Shaaban, Abeer, Wydenbach, Kirsty, Kearns, Pamela R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Consensus Statement
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7028941/
https://www.ncbi.nlm.nih.gov/pubmed/31907370
http://dx.doi.org/10.1038/s41416-019-0653-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7028941/
https://www.ncbi.nlm.nih.gov/pubmed/31907370
http://dx.doi.org/10.1038/s41416-019-0653-9

Ejemplares similares